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Penile Intraepithelial Neoplasia Is Frequent in
HIV-Positive Men with Anal Dysplasia
Alexander Kreuter1, Norbert H. Brockmeyer1, Soenke J. Weissenborn2, Thilo Gambichler1, Markus Stu¨cker1,
Peter Altmeyer1, Herbert Pfister2 and Ulrike Wieland2, for the German Competence Network HIV/AIDS
Anogenital human papillomavirus (HPV)-infection is common in HIV-infected men who have sex with men
(HIVþMSM). These patients have a strongly increased risk of HPV-induced anal cancer and its precursor lesion,
anal intraepithelial neoplasia (AIN), and a moderately increased risk for penile cancer. Only limited data exist on
penile intraepithelial neoplasia (PIN) in HIVþMSM. We determined the prevalence and evaluated the virologic
characteristics of PIN and AIN in 263 HIVþMSM. In case of histologically confirmed PIN (and AIN), HPV-typing,
HPV-DNA load determination, and immunohistochemical staining for p16INK4a were performed. PIN was detected
in 11 (4.2%) and AIN in 156 (59.3%) patients. Ten PIN patients also had AIN within the observation period. Four
clinical types of PINs could be distinguished. High-risk-a-HPV-DNA was found in 10 PIN lesions, with HPV16 being
the most frequent type. Infections with multiple HPV-types were common. All high-grade lesions had high-
risk-HPV-DNA-loads X1 HPV-copy/b-globin-gene-copy. Cutaneous b-HPVs were found in PIN and AIN, but
b-HPV-DNA loads were very low, irrespective of the histological grade. p16INK4a Expression was detectable in all
PIN lesions and correlated both with the histological grade and with high-risk HPV-DNA loads. In view of the PIN
prevalence found in our study, all HIVþMSM should be screened for PIN in addition to AIN screening.
Journal of Investigative Dermatology (2008) 128, 2316–2324; doi:10.1038/jid.2008.72; published online 3 April 2008
INTRODUCTION
Human papillomaviruses (HPV) cause a wide spectrum of
epithelial tumors ranging from benign warts to anogenital
cancers. Almost all cases of cervical and anal cancer, and the
majority of basaloid and warty penile cancers are HPV-
associated (Munoz et al., 2003; Gross and Pfister, 2004;
Palefsky, 2006). Phylogenetically, HPV are classified into
genera a-, b-, g-, m-, and n-papillomavirus (de Villiers et al.,
2004). b-, g-, m/n, and some a-HPV infect the skin, whereas
the majority of a-HPV is found on anogenital mucous
membranes and the adjacent skin. a-HPV types regularly
found in anogenital cancers as HPV16 or 18 are considered
high-risk (HR) HPV types, in contrast to low-risk HPV types
(for example, HPV6, 11), which are regularly found in genital
warts and in low-grade dysplasias, but rarely in cancers
(Munoz et al., 2003). The precursor lesions of anogenital
cancers are called intraepithelial neoplasias, such as cervical
(CIN), anal (AIN), or penile (PIN) intraepithelial neoplasia.
HPV-DNA has been found in 70–100% of PINs and in
29–81% of invasive penile cancers (depending on the
histological type), with HPV16 being the most prevalent type
(Barrasso et al., 1987; Aynaud et al., 1994; Dillner et al.,
2000; Rubin et al., 2001; Ferreux et al., 2003; Lont et al.,
2006; Senba et al., 2006). HIV infected men who have sex
with men (HIVþMSM) have a strongly increased risk for
development of AIN and anal cancer (Frisch et al., 2000;
Palefsky et al., 2005, 2006; Grulich et al., 2007). Highly
active antiretroviral therapy is not associated with reduction
of AIN (Palefsky et al., 2005). Although up to 29% of younger
men bear HR-HPV-DNA on the penis, PIN/penile cancer is a
relatively rare disease in immunocompetent patients in Europe
and North America and mostly elderly men are affected
(Dillner et al., 2000; van der Snoek et al., 2003; Nielson et al.,
2007). Compared with HIV-negative men, those HIV positive
have a somewhat higher penile HPV prevalence (van der
Snoek et al., 2003; Sirera et al., 2006). Concerning PIN/penile
cancer in HIV-positive men, only few data exist (Frisch et al.,
2000; Gomousa-Michael et al., 2000; Porter et al., 2002;
Grulich et al., 2007). The goal of this study was to determine
the prevalence of PIN/penile cancer and to identify associated
HPV types in a cohort of 263 HIV-positive MSM.
RESULTS
Prevalence of AIN and PIN
A total of 263 HIV-positive MSM were prospectively
screened for the presence of anogenital lesions. A total of
156 patients (59.3%) presented with anal dysplasia of any
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grade. In 82 patients (31.2%) high-grade AIN (AIN2/AIN3/
HSIL) and in 86 patients (32.7%) low-grade AIN (AIN1/LSIL)
was diagnosed within the observation period. Twelve patients
with low-grade AIN developed high-grade AIN in the course
of the study. A total of 69 (44.2%) of the 156 patients with
AIN had more than one episode of AIN. Nine (5.8%) of the
156 AIN lesions were subclinical (6 AIN1, 3 AIN2). Six
patients (2.3%) had invasive anal cancer (5 squamous cell
carcinomas (SCCs), 1 adenocarcinoma). PIN was diagnosed
in 4.2% of all patients (11/263), in 6.4% of patients with AIN
of any grade (10/156), in 4.1% of patients with low-grade AIN
(3/74), and in 8.5% of patients with high-grade AIN (7/82).
Six of the 11 PIN patients had PIN grade 3 (PIN3), two PIN2
and three had PIN1 (Table 1). No patient had invasive penile
cancer. Five patients presented with PIN at the baseline visit
(patients 1, 3, 4, 5, 9) and six patients (patients 2, 6, 7, 8, 10,
11) developed PIN within the course of the study (incident
cases). Ten of the 11 PIN patients also had AIN within the
observation period: five patients had concomitant AIN and
PIN, four patients had AIN 2–18 months before developing
PIN, and one patient first had PIN and 16 months later had
AIN (Table 1). We could observe four clinical types of
PIN, bowenoid (36%, n¼ 4), verrucous (27%, n¼ 3),
erythroplakic (18%, n¼2), and leukoplakic (18%, n¼ 2)
PIN (Table 1; Figure 1). Each patient exhibited only one type
of PIN. Subclinical PIN lesions were not observed. Patients
with verrucous or erythroplakic PIN had the same clinical
type of AIN, whereas all patients with bowenoid and one
patient with leukoplakic PIN had different clinical types of
AIN (Table 1). Patient’s age at diagnosis of PIN ranged
between 33 and 69 (mean 49) years, and the time between
diagnosis of HIV-infection and PIN diagnosis ranged between
1 and 16 (mean 10) years. With the exception of two patients
(no. 8,11), all PIN patients received highly active antiretro-
viral therapy. A total of 64% of the PIN patients were in CDC
stage C3, compared with 32% in the whole cohort and their
mean CD4 counts were lower (396 ml1 compared with 476
in all patients). Five PIN patients were circumcised before
study entry: one patient since his first year of life (patient 9)
and four patients due to prior removal of penile condylomas
(patient 1, 5, 7, 10). The risk for anal dysplasia of any grade
was enhanced in smokers (93/143, 65%) compared with non-
smokers (63/120, 52.5%) (odds ratio¼1.68 (95% confidence
interval 1.02–2.77)). For PIN, the risk increase in smokers
(8/143, 5.6%) compared with non-smokers (3/120, 2.5%) was
not significant (odds ratio¼2.31 (95% confidence interval
0.60–8.91)).
In contrast to anal cytology and histology, penile cytology
correlated with penile histology only in 7 of the 11 cases. In
three patients the grade of PIN was underestimated by
cytology (patients 2, 5, 6) and in one patient (patient 11),
cytology was not evaluable due to scant cellularity (Table 1).
Eight of the 11 PIN lesions were treated with electro-
cautery and/or circumcision, depending on size and localiza-
tion. In two patients, PIN lesions were surgically removed.
One patient (patient 3) refused treatment and was lost to
follow-up. Depending on the site end extension, AIN was
treated with electrocautery, 85% trichloroacetic acid, or
imiquimod as previously described (Palefsky, 2006;
Wieland et al., 2006).
HPV spectrum and HPV-DNA load in patients with PIN
and AIN
HPV-DNA was found in 10 of the 11 PIN patients. In one
patient with focal PIN1 (patient 8), no HPV-DNA was
detectable in the penile lesion. All other PIN patients carried
1–6 different HR-a-HPV types, with HPV16 being the most
frequent type occurring in eight (73%) PIN lesions. Two
HPV16-negative high-grade PIN lesions carried HR types 26,
31, 39 (patient 1) or 35 (patient 6). Low-risk a-HPV types
were found in five PIN lesions (Table 1). Histological signs of
HPV infection (koilocytes) were detectable in 8 of the 11 PIN
lesions (patients 2–5, 8–11), including in the HPV-DNA-
negative PIN1. HR-a-HPV types were detected in all AIN
lesions of the patients with PIN and in 96% (150/156) of all
anal dysplasias, with HPV16 again being the most frequent
type (109/156, 70%). A total of 80% of the AIN patients with
PIN (Table 1) and 87% (136/156) of all AIN patients carried
additional anal low-risk a-HPV types. b-HPV-DNA was
found in four PIN and five AIN lesions of 7 of the 11 patients
shown in Table 1. The maximum number of b-HPV types
found in a lesion was seven (patient 10). Eight of the 11
patients had one or more identical a- or b-HPV types in their
PIN and AIN lesions (Table 1). In patients with AIN and PIN
(n¼10), the mean/median numbers of HPV-types were
slightly higher in AIN than in PIN lesions, but the differences
were not significant (for example, HR-a-HPV types: 2.8/3 vs
1.8/1, P¼ 0.105; aþ b HPV types: 5.7/5 vs 4.4/2, P¼0.441,
Wilcoxon test). The total number of HPV types and the
number of HR-a-HPV types were significantly higher in
verrucous PIN/AIN (n¼ 8) than in non-verrucous (bowenoid,
erythroplakic, leukoplakic, n¼13) PIN/AIN (mean number
aþb HPV types: 8.3 (verrucous) vs 3.1 (non-verrucous),
P¼0.010; mean number HR-a-HPV types: 3.4 (verrucous) vs
1.7 (non-verrucous), P¼ 0.037, Mann–Whitney test). All
patients with 10 or more HPV types per lesion had verrucous
PIN (patients 1, 5) or AIN (patients 5, 11) (Table 1).
HPV-DNA loads of HR-a-HPV types 16, 18, 31, and 33
were X1 HPV copy per b-globin gene copy for at least one
HR type in all 12 cases of PIN2/3 and AIN2/3 that carried the
respective types, and around or above 100 in 4 of 7 PIN2/3
and in 4 of 5 AIN2/3 cases analyzed (Table 1). HR-a-HPV-
DNA loads below 1 were found in the PIN1 cases. In contrast
to elevated HR-a-HPV loads in high-grade AIN/PIN, b-HPV-
DNA loads were generally very low, irrespective of the grade
of AIN or PIN (oo1 HPV copy per b-globin gene copy).
Only one patient with PIN1 (patient 10) had higher b-HPV
loads (0.9 and 0.5) than HR-a-HPV loads (0.1 and 0.03)
(Table 1). Mean and median cumulative HR-a-HPV load of
PIN and AIN lesions were 3 orders of magnitude higher than
cumulative b-HPV loads (632 vs 0.25 (mean) and 54 vs 0.02
(median), P¼ 0.025, Wilcoxon test). When comparing HR-a-
HPV loads of the few patients that had penile and anal lesions
of the same grade and carried the same quantifiable HR types
in these lesions, penile loads were higher than anal loads in
these three patients (patients 1–3).
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p16INK4a expression in PIN
p16INK4a expression, which is an indirect marker of HPV-E7
oncogene expression, was detectable in all PIN lesions by
immunohistochemistry (Table 1; Figure 2). The percentage of
p16-positive cells correlated both with the histological grade
of PIN (n¼ 11, Spearman coefficient of rank correlation:
0.881, Po0.001) and with cumulative HR-HPV-DNA loads
(n¼9, Spearman coefficient of rank correlation: 0.854,
P¼0.003).
DISCUSSION
HPV-associated PIN is considered a precursor of some forms
of penile SCC. In immunocompetent patients, only 5–30% of
PIN cases will progress to invasive SCC and even high-grade
PIN lesions may regress spontaneously (Gross and Pfister,
2004). In western countries, penile cancer is a rare disease
that occurs mainly in elderly patients (Dillner et al., 2000). In
HIV-positive men, an increased risk for penile cancer
compared with HIV-negative men has been shown, but the
figures are much lower than those reported for anal cancer
(Frisch et al., 2000). In a recent meta-analysis comprising 21
cases of penile cancer and 303 cases of anal cancer, Grulich
et al. (2007) calculated standardized incidence ratios of 4.42
for penile and of 28.75 for anal cancer of HIV/AIDS patients.
Concerning PIN in HIV-positive men, only few reports exist.
Bernard et al. (1992) found that HIV-positive men more
frequently had high-grade AIN/PIN than those HIV-negative.
Gomousa-Michael et al. (2000) describe five low- and 10
high-grade PINs detected in 30 HIV-positive patients with
penile lesions, compared with 10 low- and two high-grade
PINs found in 40 HIV-negative men with penile lesions. To
our knowledge, prevalence data for PIN in HIV-positive men
have not yet been reported. In this study, we have screened
263 HIV-positive MSM and have found AIN in 59.3% and
PIN in 4.2% of all patients, with about half of the AIN and
73% of the PIN lesions being high-grade lesions. The AIN
prevalence found in our study is comparable to previous
studies reporting high rates of AIN in HIV-positive men
(Palefsky et al., 2005, 2006). The fact that PIN is less frequent
than AIN is in line with the above mentioned numbers for the
respective invasive cancers in HIV-positive men. Further-
more, in studies comparing penile and anal HPV-DNA
prevalence of MSM, penile HPV prevalence has been lower
than anal HPV prevalence (van der Snoek et al., 2003; Sirera
et al., 2006). This suggests both a lower susceptibility of the
penile epithelium for HPV infection and a lower risk of
dysplasia/cancer development of penile HPV infections
compared with the anal transformation zone.
Two-thirds of the patients with PIN were in CDC stage C3,
compared with one-third in the whole cohort. In a study by
Porter et al. (2002) all HIV-infected patients with PIN had
CD4 counts below 200mm3. In our study, only two of the
11 PIN patients had CD4 counts below 200 ml1 and eight
had below 500 ml1. However, mean and median CD4
counts were lower in PIN patients compared with the whole
a b
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Figure 1. Four clinical types of PIN in HIV-positive men. (a) Slightly scaling,
verrucous plaque affecting the complete glans penis (verrucous PIN, patient
5). (b) Sharply defined, dark red, glistening, velvety, non-tender, eroded
plaque on the glans penis, coronal sulcus, and prepuce (erythroplakic PIN,
patient 4). (c) Multiple, slightly elevated, red papules on the glans penis
(bowenoid PIN, patient 3). (d) Slightly infiltrated, white to reddish plaque on
the prepuce (leukoplakic PIN, patient 2).
Figure 2. Immunohistochemical staining of a PIN lesion for p16INK4a.
Penile intraepithelial neoplasia grade 3 (patient 4). Immunohistochemical
analysis (detail) using anti-p16 monoclonal antibody demonstrates a strong
immunoreactivity for p16 both in the nuclei and the cytoplasm, reaching the
upper third of the epidermis (82% of cells were p16-positive in the complete
biopsy specimen; original magnification  40). Focal areas of p16-negative
cells were observed. Bar¼0.1mm.
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cohort. Three clinical variants of PIN3 have been described,
bowenoid papulosis, Bowen’s disease, and erythroplasia of
Queyrat (EQ) (Gross and Pfister, 2004). We have recently
tried to categorize perianal AIN in four clinical types,
bowenoid, erythroplakic, leukoplakic, and verrucous AIN
(Kreuter et al., 2005). This classification might also be
suitable for all grades of PIN, with bowenoid PIN corre-
sponding to bowenoid papulosis and erythroplakic PIN to
EQ. Verrucous PIN partially resembles Bowen’s disease
(well-demarcated scaly plaques); however, hyperkeratotic
forms of this PIN type have condylomatous aspects.
Leukoplakic PIN does not correspond to bowenoid papulosis,
Bowen’s disease, or EQ. Porter et al. (2002) have recently
described the clinical spectrum of 35 PIN cases. All of their
eight HIV-positive patients presented with bowenoid
papulosis, one additionally with Bowen’s disease and EQ.
In contrast to Porter et al., only 4 of our 11 PIN patients had
bowenoid PIN. PIN2/3 occurred with all clinical types, but all
PIN1 lesions were bowenoid or leukoplakic.
HR-a-HPV-DNA was detectable in all PIN cases, with the
exception of a case of focal PIN1. This is in line with previous
publications that have reported HPV-DNA prevalence rates
around or above 90% in penile dysplasias of immunocom-
petent patients (Aynaud et al., 1994; Cupp et al., 1995; Rubin
et al., 2001). In two-thirds of our PIN lesions, more than one
a-HPV type was found, which is more than that reported for
penile dysplasias of HIV-negative patients (16–22%) (Aynaud
et al., 1994; Rubin et al., 2001). Higher rates of infections
with multiple HPV types have already been reported for AIN
of HIV-positive compared with HIV-negative patients (Pa-
lefsky et al., 1998). HPV16 occurred in 73% of our PIN
lesions, again more than that reported for HIV-negative
patients (41–43%) (Aynaud et al., 1994; Rubin et al., 2001).
Since HPV16 is considered more carcinogenic than other
HR-a-HPV types (Smith et al., 2007), the high HPV16
prevalence might pose a higher risk for progression to penile
cancer. The total number of HPV types, as well as the number
of HR-a-HPV types, was significantly higher in verrucous
PIN/AIN than in non-verrucous lesions, possibly indicating an
influence of the number of HPV types on the clinical picture.
However, the etiologic significance of multiple HPV types is
largely unclear. Synergistic effects of HPV types infecting the
same cell or lesion seem possible, but commensalism or
surface contamination cannot be excluded. HPV types with
low viral loads may rather be passengers than drivers.
b-HPV-DNA was found in 4 PIN and 5 AIN lesions of
seven patients. b-HPV were originally discovered in benign
skin lesions and SCC of patients with the genodermatosis
epidermodysplasia verruciformis, where they occur in high
copy numbers. These patients usually do not develop
anogenital lesions (Orth, 2006). b-HPV frequently persist in
the skin and hair bulbs of healthy individuals (de Koning
et al., 2007; Hazard et al., 2007). Only few reports on the
detection of b-HPV in mucosal/genital lesions have been
published (Favre et al., 1998; Ekeowa-Anderson et al., 2007;
Mermet et al., 2007). We speculated before that PIN
presenting as EQ could result from co-infection with HR-a-
HPV types and b-HPV type 8 (Wieland et al., 2000). In view
of the very low b-HPV loads, a commensal colonization of
the anogenital skin also seems possible. Furthermore, no b-
HPV type was detectable in the two EQ-like PIN cases of this
study. On the other hand, b-HPV loads were 10-fold higher
than HR-a-HPV loads in PIN patient 10, which could indicate
that b-HPV play a role in some cases of PIN development.
Interestingly, all four PIN patients with penile b-HPV had
been circumcised before study entry. Perhaps this facilitated
the spread of b-HPV to the distal part of the penis. The finding
that eight patients had 1–6 identical anal and penile HPV
types supports the assumption that dissemination of HPV
types between different anogenital regions occurs within a
given patient.
Several studies have shown that elevated HR-a-HPV-DNA
loads in cervical scrapes are predictive of the severity of the
underlying cervical lesion and reflect an increased risk for
cervical cancer. It has been difficult, however, to define a
clear cut-off for HR-a-HPV-DNA load indicating the presence
of advanced CIN (Ylitalo et al., 2000; Snijders et al., 2006). In
HIV-positive women, cervical HPV16-DNA loads above 1
HPV copy per b-globin gene copy were associated with HSIL
(Weissenborn et al., 2003). In this study, we determined HR-
a-HPV-DNA loads only for 4 of the 16 HR-a-HPV-types
found in the PIN and AIN lesions (HPV16, 18, 31, and 33).
All patients with PIN2/3 or AIN2/3 had HR-a-HPV loads at or
above this level, but some patients with AIN1 also had high
viral loads. However, HR-a-HPV-DNA loads below 1 were
consistently found in PIN1 lesions, one of which may have
been caused by low-risk types 11 and/or 54. a-HPV-DNA
loads were also determined for low-risk HPV types 6 and 11
(Kreuter et al. 2006). HPV6/11 loads did not correlate with
the grade of dysplasia (data not shown). All HPV6/11 positive
patients shown in Table 1 had a history of penile or anal
condylomata acuminata.
p16INK4a Expression is an indirect marker of HPV-E7
oncogene expression and p16INK4a immunohistochemistry is
a suitable marker for detection and grading of CIN,
independent of the infecting HR-a-HPV type (Sano et al.,
1998; Vinokurova et al., 2005). Ferreux et al. (2003) found
p16INK4a staining in 65% of HPV-positive, in 6% of HPV-
negative, in 81% of HR-a-HPV-DNA-positive, and in 92% of
HPV16-positive penile carcinomas. In our study, p16
expression was detectable in all PIN lesions, also in an
HPV-negative focal PIN1 with few p16-positive cells.
Probably this PIN lesion also carried low amounts of HR-a-
HPV-DNA that were missed by PCR. The percentage of p16-
positive cells correlated both with the histological grade of
PIN and with cumulative HR-a-HPV-DNA loads as pre-
viously described for CIN and AIN (Vinokurova et al., 2005;
Kreuter et al., 2007). This makes p16 a useful adjunct for the
diagnosis and grading of PIN.
A drawback of our study is the inconsistent observation
periods of the individual patients ranging from a single visit to
38 months. PIN and AIN rates might have been higher if all
patients could have been followed for a longer period of time.
A further limitation is that penile swabs/biopsies were only
obtained in case of clinically visible lesions and/or high-
resolution anoscopic signs indicating HPV-related disease.
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Therefore some early or discrete PIN lesions could have
been missed.
In summary, we have detected a surprisingly high number
of HIV-positive AIN patients who additionally developed
PIN. Since HIV-positive patients have an increased risk for
penile cancer (Frisch et al., 2000; Grulich et al., 2007), and
since explosive courses of penile SCC in AIDS patients have
been described (Aboulafia and Gibbons, 2001; Theodore
et al., 2002), all HIV-positive MSM should regularly be
screened for PIN in addition to AIN screening.
MATERIALS AND METHODS
Patients
Between October 2003 and December 2006, 263 White,
HIV-positive MSM were screened every 6 months for HPV-related
diseases in the context of a sub-study of the German ‘‘Kompetenz-
netzwerk HIV/AIDS’’ basically as previously described (Kreuter
et al., 2005). The medical ethical committee of the Ruhr University
of Bochum approved the study protocol. The study was conducted
according to Declaration of Helsinki Principles. Patients gave written
informed consent to participate in the study. At study entry, patients’
ages ranged between 19 and 69 years (mean 41, median 40). CD4
counts were between 5 and 1,476 ml1 (mean 476, median 456), and
HIV-1 RNA loads were between o40 and 2,710,000 copiesml1
(mean 47,905, median 79). A total of 87 patients were in CDC stage
A, 89 in B, 83 in C, and CDC stage was unknown for 4 patients. A
total of 186 (71%) of the 263 patients received highly active
antiretroviral therapy at study entry. A total of 143 patients were
smokers (54%) and 120 non-smokers (46%). The mean follow-up
time was 11 months (range 0 (single visit)—38 months). Eight
patients were circumcised before study entry: one patient (patient 9;
Table 1) in his first year of life, one patient 25 years before study
entry (phimosis surgery), and six patients between 1 and 5 years
before study entry (four due to surgical removal of penile
condylomas (patients 1, 5, 7, 10), one due to Kaposi sarcoma
surgery, one due to cosmetic (piercing) surgery).
Clinical examination, cytology, and histology
All participants underwent standardized HPV-screening program at
the Department of Dermatology of the Ruhr University Bochum, as
previously described (Berry et al., 2004; Kreuter et al., 2005).
Clinical examination included inspection of the oral cavity, glans
penis, corona, sulcus, frenulum, the inner part of the foreskin,
scrotum, inguinal folds, perianal skin, anal squamous-columnar
transitional zone (dentate line), and anal canal. Application of 3%
acetic acid was used to detect subclinical anal and penile lesions.
Mucous membranes were 30-fold magnified using high-resolution
anoscopy (Kolposkop 150 FC; Zeiss, Oberkochen, Germany). Penile
lesions were categorized as follows: (1) condylomata acuminata
(exophytic lesions with irregular surface and terminal capillaries); (2)
lesions suspicious of PIN (clinical features as reported by Porter et al.
2002; Kreuter et al. 2005); (3) subclinical lesions (lesions only visible
after application of acetic acid with signs of HPV-related disease
such as punctuation or mosaic as reported by Gross and Pfister,
2004); and (4) unspecific lesions (acetowhitening seen after
application of acetic acid, mainly caused by traumatic abrasions,
superficial erosions, or inflammation such as balanitis without any
signs of HPV-infection; (Gross and Pfister, 2004)). Punch biopsies
measuring 3mm were obtained after local anesthesia in conditions
1, 2, and 3. All 28 biopsies taken from condylomata acuminata were
histologically confirmed. The same was true for 11 biopsies
suspicious of PIN (see Results). All biopsies (n¼ 22) taken from
subclinical lesions revealed no signs of dysplasia.
Swabs for cytology and HPV analyses were obtained as described
previously (Kreuter et al., 2005). Cytological results were reported
according to the Bethesda system as normal, ASCUS (atypical
squamous cells of undetermined significance), LSIL (low-grade
squamous intraepithelial lesion), HSIL (high-grade squamous in-
traepithelial lesion), or cancer. AIN and PIN were histologically
classified as grades 1–3 depending on the degree of dysplasia.
Histological results were evaluated independently by two histo-
pathologists without knowledge of the clinical status. In case of
discrepancies, all specimens were assessed by a third observer.
HPV-DNA analyses
DNA isolation and HPV-DNA analyses were performed as described
before (Kreuter et al., 2005; de Koning et al., 2006). Briefly, DNA
was isolated using the QIAamp DNA Mini kit (Qiagen, Hilden,
Germany) and b-globin gene PCR was carried out to demonstrate
that the samples contained adequate DNA and were free of
substances inhibitory to PCR (Kreuter et al., 2005). The samples
shown in Table 1 were analyzed by different PCRs for the detection
of a- and b-HPV-DNA as previously described (Kreuter et al., 2005;
de Koning et al., 2006). Briefly, A5-A10 nested PCR was used for the
detection of a-HPV-DNA (Wieland et al., 2000). For HPV typing,
internal biotinylated PCR products were hybridized with 37 type-
specific digoxigenin-labelled oligonucleotide probes in an enzyme
immunoassay (Jacobs et al., 1997; Kreuter et al., 2005). Pluck me
(PM)-PCR followed by a reverse hybridization assay (DDL,
Voorburg, the Netherlands) was used for the detection and typing
of 25 different b-HPV types (de Koning et al., 2006). HPV-DNA loads
were determined by real-time PCRs, with type-specific primers and
probes for a-HR-HPV types 16, 18, 31, and 33 (Weissenborn et al.,
2003), and for b-HPV types 5, 8, 15, 20, 23, 36, and 38, as described
earlier (Wieland et al., 2000; Weissenborn et al., 2005). HPV-DNA
loads were expressed as HPV-DNA copies per b-globin gene copy
(Weissenborn et al., 2003).
Immunohistochemical staining for p16INK4a
p16INK4a Staining of 3-mm paraffin-embedded sections of penile
biopsies was performed using the CINtec p16INK4a Histology kit
(DakoCytomation, Hamburg, Germany) according to the manufac-
turer’s instructions, as previously described (Kreuter et al., 2007).
Nuclear staining with or without cytoplasmatic staining was
considered positive for p16INK4a. Quantitative results were expressed
as the percentage of positive cells per field on total cell count
(Table 1). Only cells within the epidermis were counted. All sections
were separately evaluated by two histopathologists without knowl-
edge of the histological diagnosis. If there was a difference of more
than 5%, sections had to be re-evaluated by both the observers.
Statistical analysis
Statistical analyses were performed with SPSS 11.0. 1 (SPSS Inc.,
Chicago, IL), using Wilcoxon test (paired samples) and Mann–Whit-
ney test (independent samples) for assessment of non-normally
distributed data. Correlation studies were conducted using Spearman
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coefficient of rank correlation. The risk of anal dysplasia was
estimated by means of odds ratios, including its 95% confidence
interval. Since this was an explorative study, we did not constrain
experiment-wise error rates due to multiple comparisons. P-values
less than 0.05 were considered statistically significant.
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